Sep 2026· Babcock University Medical Journal· 0 citations· 29 references
TL;DR
The combined in silico in vitro strategy was found to be useful in expediting anticancer lead discovery, and it aids in using computational-experimental pipelines in rational drug design.
Abstract
Objective: The current paper was to determine and assess the new heterocyclic thiazolidinone analogues as potential therapeutic agents in androgen-independent prostate cancer (AIPC) through the combined efforts of computational (in silico) and experimental (in vitro) designs in the androgen receptor.
Methods: A combined Density Functional Theory (DFT), molecular docking and pharmacokinetic prediction research strategy was used. First, the thiazolidinone derivatives were constructed, and the electronic properties and stability were examined with DFT. The interaction and binding affinity of the compounds with the androgen receptor were then studied by means of molecular docking. SwissADME and ADMETlab tools were used to predict drug-likeness, pharmacokinetic behaviour and toxicity profile. Lead compounds with promising results of computational analysis were prepared and subsequently tested with respect to cytotoxicity in PC-3 prostate cancer cell lines by the in vitro assays.
Results: The computational study showed that some of the thiazolidinone derivatives showed a high binding interaction with the androgen receptor. Of them, analogues containing halogen were found to possess improved receptor affinity and good pharmacokinetic characteristics. The structure-activity relationship was confirmed by the in vitro cytotoxicity studies of PC-3 cells, which demonstrated that these compounds had a higher biological activity due to their structure-activity relationship based on computational modelling.
Conclusion: The results demonstrate the therapeutic efficiency of electronically optimised derivatives of thiazolidinone regarding androgen-independent prostate cancer. The combined in silico in vitro strategy was found to be useful in expediting anticancer lead discovery, and it aids in using computational-experimental pipelines in rational drug design.
The improved binding affinity of the designed derivatives compared to scopoletin suggests that structural modifications of the coumarin nucleus enhanced their interaction with Topoisomerase IIα, a crucial enzyme involved in DNA replication and a validated target in cancer therapy.
A. Pandey, Anuvanshika Yadav, Anupam Tiwari et al.· Biological sciences· 0 citations
The utility of structure-based virtual screening combined with ADMET prediction as an effective strategy for early-stage lead identification in prostate cancer drug discovery and the improved predicted pharmacokinetic properties suggest that rational modification of heterocyclic scaffolds can yield AR antagonists with...
Vanktesh Kumar, Shivank Sharma, Saminesh Kumar et al.· Current Organocatalysis· 0 citations
This experimental and computational study identifies para-substituted derivatives 4d as a promising lead for further development as a non-steroidal aromatase inhibitor for breast cancer therapy.
A. Işık, Nour El-huda Daoud, Kezban Uçar Çiftçi et al.· Future Medicinal Chemistry· 0 citations
VS-04 was identified as a promising oxadiazole–pyrazole lead with potent antiproliferative activity against prostate cancer cells, which was associated with AR modulation, oxidative stress, cell-cycle perturbation, and apoptotic cell death.
The growing problem of antimicrobial resistance has created a need for new agents; a new class of pyrimidine derivatives was synthesized, and their biological potential was determined by in vitro and in silico analyses. Pyrimidine derivatives were designed and synthesized in the wet lab. The Structures of the compounds...
Minakshi, Mahesh Kumar· Genetics and Molecular Resea...· 0 citations
A series of diphenylpropan-1-one (DPP) derivatives (4a–4i), rationally designed around a chalcone framework and synthesized via a three-step reaction sequence demonstrated encouraging preliminary anticancer potential and may serve as promising lead molecules for future investigations.
A. Najmi, M. S. Alam, W. Ahsan et al.· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.